Tsukamoto A, Kaneko Y, Kurokawa K
First Department of Medicine, University of Tokyo, Japan.
Experientia. 1992 May 15;48(5):495-7. doi: 10.1007/BF01928172.
A topoisomerase II inhibitor, novobiocin, and a deacetylase inhibitor, butyrate, synergistically transformed human liver cells into fibroblast-like cells. This morphological change was associated with an increased production of procollagen type III peptide and a simultaneous assembly of actin, tubulin, vimentin and cytokeratin. Novobiocin and butyrate had no marked effect on the phosphorylation state of cytokeratin proteins, but synergistically enhanced [3H]acetate uptake. From these results, it can be speculated that protein acetylation plays an important role in inducing the assembly of cytoskeletal proteins and the morphological transformation of human liver cells.
一种拓扑异构酶II抑制剂新生霉素和一种脱乙酰酶抑制剂丁酸盐可协同将人肝细胞转化为成纤维细胞样细胞。这种形态变化与III型前胶原肽产量增加以及肌动蛋白、微管蛋白、波形蛋白和细胞角蛋白的同时组装有关。新生霉素和丁酸盐对细胞角蛋白的磷酸化状态没有显著影响,但可协同增强[3H]乙酸盐摄取。从这些结果可以推测,蛋白质乙酰化在诱导细胞骨架蛋白组装和人肝细胞形态转化中起重要作用。